Concepedia

Georgia Kollia

GK

Statistics

Publications

56

Citations

19.7K

H-Index

31

Active since

1988

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

Dana-Farber Cancer Institute

Sidney Kimmel Comprehensive Cancer Center

Johns Hopkins University

Georgia Kollia is an author at Bristol-Myers Squibb (United States) specializing in oncology, cancer immunotherapy, and medicine.

Publications per year

1988–2024

56

Publications

56

Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

Suzanne L. Topalian, F. Stephen Hodi, Julie R. Brahmer et al. · New England Journal of Medicine · 2012 · 12.7K citations · Full text

, , +17

Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab

Suzanne L. Topalian, Mario Sznol, David F. McDermott et al. · Journal of Clinical Oncology · 2014 · 2.2K citations

, , +17

Overall Survival and Long-Term Safety of Nivolumab (Anti–Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer

Scott Gettinger, Leora Horn, Leena Gandhi et al. · Journal of Clinical Oncology · 2015 · 1.2K citations · Full text

, , +17

Survival, Durable Response, and Long-Term Safety in Patients With Previously Treated Advanced Renal Cell Carcinoma Receiving Nivolumab

David F. McDermott, Charles G. Drake, Mario Sznol et al. · Journal of Clinical Oncology · 2015 · 443 citations

, , +17

A Generalization of the Weibull Distribution with Application to the Analysis of Survival Data

Govind S. Mudholkar, Deo Kumar Srivastava, Georgia Kollia · Journal of the American Statistical Association · 1996 · 380 citations

, , +13

1–5 of 56